Boehringer Ingelheim

BOEHRINGER INGELHEIM NEWSROOM (7 press releases)

Advanced Filtering & Sorting Options:

Boehringer Ingelheim Leverages IBM’s AI Tech for Novel Antibody Development

PRESS RELEASE -- 28, November 2023

(IN BRIEF) Boehringer Ingelheim and IBM have formed a partnership to expedite the discovery of novel candidate antibodies for therapeutic purposes. Boehringer will utilize IBM’s foundation model technologies, combining them with their proprietary data to enhance the antibody discovery process. … Read the full press release

Boehringer Ingelheim Advances Dual Agonist Survodutide to Phase III Trials, Demonstrating Significant Weight Loss in Phase II Study

PRESS RELEASE -- 18, August 2023

(IN BRIEF) Pharmaceutical company Boehringer Ingelheim has declared its intention to move forward with survodutide, a dual agonist targeting the glucagon/GLP-1 receptors, into three Phase III clinical trials for individuals suffering from overweight or obesity. This decision stems from promising … Read the full press release

Boehringer Ingelheim’s New €285m Chemical Plant to Boost Pharmaceutical Innovation

PRESS RELEASE -- 2, May 2023

(IN BRIEF) Boehringer Ingelheim has begun construction on a new Chemical Innovation Plant at its headquarters in Ingelheim, Germany. The €285 million investment will develop manufacturing processes for active pharmaceutical ingredients and produce drugs for clinical trial phases, enabling Boehringer … Read the full press release

Patients as Partners Europe Returns to London and Announces Agenda Highlights

PRESS RELEASE -- 13, April 2023

(IN BRIEF) The Conference Forum has announced that the 7th annual European Patients as Partners® in Clinical Research conference will take place in London on June 12-13, 2023. The event will focus on achieving greater representation in clinical research, building … Read the full press release

Study Shows Linear Association Between Salt Intake and Atherosclerosis in Heart and Neck Arteries

PRESS RELEASE -- 1, April 2023

(IN BRIEF) A study published in the European Heart Journal – Open has found that excessive salt intake is associated with clogged arteries of the heart and neck, which is linked with increased risks of heart attack and stroke. Atherosclerosis, … Read the full press release

Boehringer Ingelheim: A Model for Employee Wellbeing in the Corporate World

PRESS RELEASE -- 17, January 2023

(PRESS RELEASE) INGELHEIM, 17-Jan-2023 — /EuropaWire/ — Boehringer Ingelheim, one of the world’s leading research-driven pharmaceutical companies with 130 years of experience, has announced it has been named a “Global Top Employer” for the third year in a row by the … Read the full press release

Boehringer Ingelheim: un modelo para el bienestar de los empleados en el mundo corporativo

PRESS RELEASE -- 17, January 2023

(COMUNICADO DE PRENSA) INGELHEIM, 17-Jan-2023 — /EuropaWire/ — Boehringer Ingelheim, una de las principales compañías farmacéuticas del mundo impulsadas por la investigación con 130 años de experiencia, ha anunciado que ha sido nombrada “Global Top Employer” por tercer año consecutivo por … Read the full press release